v' In 13 dogs the response of the cerebral circulation to changes in PaCO2 ranging from 20 to 60 torr was studied before and after administration of high doses of sodium thiopental. Infusion of sufficient barbiturate to produce 30-to 60-second burst suppression in the electroencephalogram was associated with a profound degree of cerebral vasoconstriction, equivalent to that produced by hypocapnia with PaCO2 = 20 torr. Furthermore, once sodium thiopental was administered, no significant difference in cerebral blood flow (CBF) or vascular resistance (CVR) was noted between PaCO2 of 30 and 20 torr. However, changes of approximately 15% in CBF and 30% in CVR were noted between PaCO2 at 40 and 20 torr. These data suggest that hyperventilation of PaCO2 of less than 30 torr may not effectively increase the degree of cerebral vasoconstriction in these circumstances.
R
ECENTLY, high-dose barbiturate therapy has been added to those therapeutic modalities used to treat brain swelling and intracranial hypertension. Administration of barbiturates is associated with a reduction in intracranial pressure (ICP), presumably by decreasing brain blood volume. Barbiturates depress brain metabolism and result in cerebral vasoconstriction and decreased cerebral blood flow (CBF) through the metabolic component of cerebral autoregulation. 2, 11, 19, 24 Hyperventilation causing hypocapnia also produces cerebral vasoconstriction, 1'1~176 and is well established as an effective means for lowering ICP. 8,12,22 However, hyperventilation and the associated respiratory alkaloses are not without risk. 2~ The purpose of this study was to determine whether hypocapnia results in additional cerebral vasoconstriction in the presence of high-dose barbiturate therapy.
Materials and Methods
Thirteen mongrel dogs, weighing approximately 15 kg each, were used for this study. Anesthesia was induced with intravenous chloralose (50 mg/kg) and urethane (500 mg/kg), and maintained with a nitrous oxide-oxygen mixture (70%:30%) supplemented with intravenous morphine sulfate. Muscular paralysis was achieved with pancuronium, and ventilation was controlled with a pump respirator. A total of between 2.5 and 5 mg/kg of morphine and 0.1 to 0.3 mg/kg of pancuronium was administered to each dog in divided doses. The animals were hyperventilated and CO2 added to the inspired gas mixture to maintain the PaCO2 at the desired levels.
Esophageal temperature was measured and maintained at 37.5~ with a warming blanket. Approximately 150 minutes elapsed between the time the animals were anesthetized with chloralose and urethane and the time of the first CBF determination. The duration of the experiment between first and last CBF measurements was approximately 240 minutes. In control studies performed in our laboratory, this anesthetic protocol produces a preparation that is stable in terms ofcerebrovascular, metabolic, and cardiovascular parameters over intervals of time equivalent to those used in this series of animals.
Cerebral blood flow was determined with the radio- active microsphere technique? a,14,15 In each experiment, CBF was measured six times using 15-# spheres labeled with iodine-125, carbon-145, strontium-85, tin-113, niobium-95, and scandium-46. The microspheres were injected into the left ventricle through a pigtail catheter inserted through the femoral artery and descending aorta. Blood reference samples were drawn from one femoral and one brachial artery. At the completion of the experiment, the brain was removed and divided into cerebral hemispheres, corpus callosum, brain stem, and cerebellum for determination of blood flow. End-tidal CO2, 02, and nitrous oxide were monitored continuously with a respiratory mass spectrometer.* Systemic arterial pressure was measured from a catheter placed in the brachial artery. Central venous pressure was measured from a Swan-Ganz catheter inserted into the pulmonary artery through the femoral vein and descending vena cava. This catheter also served to measure cardiac output, utilizing the thermodilution technique. Sagittal sinus pressure was measured from a catheter inserted in the anterior portion of the sagittal sinus and threaded caudally. Heart rate was derived from the electrocardiogram. These physiological parameters were continuously *Respiratory mass spectrometer, Medspect II, Model 40-20-3000, manufactured by Chemetron Medical Division, 1801 Lilly Avenue, St. Louis, Missouri.
recorded on an eight-channel strip-chart recorder. Electroencephalograph (EEG) monitoring was performed from leads screwed into the frontal and parietal bones bilaterally and recorded on an eightchannel EEG.
Immediately before each CBF determination, blood was drawn for measurement of arterial blood gases and hematocrit. Oxygen content of the sagittal sinus and systemic arterial blood was also measured.
The cerebral metabolic rate for oxygen (CMRO2) was calculated by multiplying the mean cerebral hemispheric flow by the difference between the systemic arterial and sagittal sinus oxygen content. Cerebral vascular resistance (CVR) was calculated by dividing the systemic arterial pressure minus sagittal sinus pressure by the total mean hemispheric blood flow. Peripheral vascular resistance was calculated by dividing the systemic arterial pressure by the cardiac index. Cardiac index was estimated by dividing the cardiac output by the animal's body weight.
Cerebral blood flow was determined at PaCO2 levels of 20, 30, 40, 50, and 60 torr, both before and after administration of sufficient thiopental sodium to produce EEG burst suppression averaging 30 to 60 secondsP Six CBF measurements were made in each animal. In the last seven dogs, cerebral metabolic rate of O2 was also determined. Hereafter, flows are expressed as the mean + SEM in ml/100 gm of brain tissue/rain. Statistical examination of the data was PaCO2 and barbiturate effect on CBF ml/100 gm at a PaCO2 of 40 torr, and after barbiturate administration the respective values were 1.34 + 0.13 and 2.94 + 0.31 ml/100 gm. Most notable, however, is the observation that, following high doses of sodium thiopental, there was no significant difference in CBF or CVR between a PaCO, of 30 and 20 torr. The CBF and CVR following barbiturates with a PaCO2 of 20 torr were 22 + 1 and 4 + 0.39 ml/100 gm, respectively. The changes in CBF noted above have been made in reference to mean hemispheric flow. However, a similar pattern of responses was noted in the corpus callosum, brain stem, and cerebellum (Table 2) .
Discussion
High-dose barbiturate therapy has been assuming a wider role in the management of neurological disorders characterized by cerebral ischemia and/or brain swelling and increased ICP. 8,ts,~6,~7.2~,2s Beneficial effects of this modality have been postulated in the prevention of infarction, by virtue of an antioxidant effect 4,5 and by decreasing cerebral metab-N. F. Kassel], et al. olism 11,~g,~4 and thus allowing the brain to survive with decreased CBF. However, the most thoroughly documented action of this agent is in decreasing ICP and thereby increasing cerebral perfusion pressure. Highdose barbiturates markedly decrease cerebral metabolism, and, as a result of metabolic autoregulation, also decrease CBF. This action is accompanied by cerebral vasoconstriction and decreased cerebral blood volume. It is principally through the mechanism of decreased blood volume and brain bulk that barbiturates reduce ICP.
Hypocapnia from hyperventilation also reduces CBF and cerebral blood volume. 6,12,2~ In contrast to barbiturates, hypocapnia does not lower brain metabolism} ,1~ Thus, in certain situations, extreme degrees of hypocapnia can result in cerebral ischemia75 Although hyperventilation is an effective mechanism for controlling intracranial hypertension, it is not without risk (especially when prolonged for several days or more).
The degree of cerebral vasoconstriction produced by high doses of sodium thiopental has not been documented in absolute terms or relative to the effect of hypocapnia. It has not been established that hyperventilation and barbiturates have a complementary effect in increasing cerebral vasoconstriction.
In this study, sodium thiopental was administered in doses sufficient to produce EEG burst-suppression of 30 to 60 seconds. This dose has been shown to produce the maximum cerebral vasoconstriction possible with sodium thiopental while producing minimal cardiovascular depression)
In terms of reduction in CBF and increases in CVR, the degree of cerebral vasoconstriction produced by these doses of barbiturate at a PaCO2 of 40 torr is equivalent to that produced by hypocapnia to a PaCO~ of 20 torr in the absence of barbiturates. Furthermore, the reactivity of the cerebral vessels to changes in PaCO2 is markedly blunted by barbiturates, and minimal further cerebral vasoconstriction results from a reduction in PaCO2 from 30 to 20 torr. This suggests that, unless extremely compelling reasons arise, it is probably best to maintain PaCO2 at approximately 30 torr during high-dose barbiturate therapy.
Caution must be exercised in extrapolating the conclusions derived herein from dogs with normal central nervous and cardiovascular function to the clinical situation. There may also be a species difference between dogs and humans in responsiveness to sodium thiopental. Since this study was performed using sodium thiopental, the results may be different from those obtained with other barbiturates.
